摘要:
The invention relates to novel dendritic polymers having biphosphonic terminations, to derivatives thereof, to a method for preparing them and to their uses.
摘要:
The invention relates to novel dendritic polymers having monophosphonic terminations or dimethyl phosphonates, to a method for preparing them, and to their uses.
摘要:
The invention relates to novel dendritic polymers having biphosphonic terminations, to derivatives thereof, to a method for preparing them and to their uses.
摘要:
The invention relates to novel dendritic polymers having monophosphonic terminations or dimethyl phosphonates, to a method for preparing them, and to their uses.
摘要:
A method for treating inflammatory diseases through an anti-inflammatory type activation of monocytes, the method includes the administration to a patient in need thereof of an effective quantity of at least one dendrimer with mono- or biphosphonic terminations.
摘要:
The present invention relates to solid supports functionalized with phosphorus-containing dendrimers, to a process for preparing them, to their use for preparing biochips and to the uses of these biochips, in particular for immobilizing molecules of interest, especially biological molecules of interest such as nucleic acids, polypeptides, lipids and proteins.
摘要:
The present invention relates to solid supports functionalized with phosphorus-containing dendrimers, to a process for preparing them, to their use for preparing biochips and to the uses of these biochips, in particular for immobilizing molecules of interest, especially biological molecules of interest such as nucleic acids, polypeptides, lipids and proteins.
摘要:
The present invention relates to dendrimers with a monosaccharide, oligosaccharide or polysaccharide terminal group, to their preparation method and their therapeutic uses, notably anti-inflammatory uses.
摘要:
Fluorescent chemical compound composed of an n-generation dendrimer, n being a non-zero integer, exhibiting: —at least one central nucleus (N) with a valency of m, selected from the group consisting of—at least one first, non-chromophoric unit (X) with a valency of m′, and—at least one second unit (Y) which exhibits two-photon absorption properties, with a valency of m″.
摘要:
The invention concerns phosphorus-containing dendrimers and their uses, as gene transfection agents, in vitro and in vivo, including in the treatment of human and animal diseases. These agents or vectors are in particular suited for delivering to appropriate target cells, nucleic acid sequences of interest.